US Bancorp DE Sells 11,457 Shares of Bath & Body Works, Inc. (NYSE:BBWI)

US Bancorp DE trimmed its position in Bath & Body Works, Inc. (NYSE:BBWI) by 68.8% during the third quarter, HoldingsChannel.com reports. The institutional investor owned 5,197 shares of the company’s stock after selling 11,457 shares during the period. US Bancorp DE’s holdings in Bath & Body Works were worth $166,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently added to or reduced their stakes in the company. New York State Teachers Retirement System grew its stake in shares of Bath & Body Works by 18.1% in the third quarter. New York State Teachers Retirement System now owns 266,235 shares of the company’s stock valued at $8,498,000 after acquiring an additional 40,793 shares in the last quarter. Abich Financial Wealth Management LLC bought a new stake in Bath & Body Works in the 3rd quarter valued at about $103,000. State of Alaska Department of Revenue grew its position in shares of Bath & Body Works by 418.2% during the 3rd quarter. State of Alaska Department of Revenue now owns 127,226 shares of the company’s stock worth $4,061,000 after purchasing an additional 102,675 shares in the last quarter. Wealth Enhancement Advisory Services LLC bought a new position in shares of Bath & Body Works during the third quarter worth approximately $343,000. Finally, Mirae Asset Global Investments Co. Ltd. raised its position in shares of Bath & Body Works by 69.9% in the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 18,092 shares of the company’s stock valued at $586,000 after buying an additional 7,443 shares in the last quarter. Institutional investors own 95.14% of the company’s stock.

Bath & Body Works Stock Performance

Shares of NYSE:BBWI opened at $31.34 on Friday. Bath & Body Works, Inc. has a 52-week low of $26.20 and a 52-week high of $52.99. The company has a market capitalization of $6.87 billion, a PE ratio of 7.59, a price-to-earnings-growth ratio of 1.00 and a beta of 1.79. The company has a fifty day moving average of $30.12 and a 200-day moving average of $36.60.

Bath & Body Works (NYSE:BBWI) last issued its earnings results on Wednesday, August 28th. The company reported $0.37 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.35 by $0.02. The business had revenue of $1.53 billion during the quarter, compared to analysts’ expectations of $1.54 billion. Bath & Body Works had a negative return on equity of 41.94% and a net margin of 12.69%. On average, equities analysts forecast that Bath & Body Works, Inc. will post 3.18 EPS for the current fiscal year.

Bath & Body Works Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 6th. Investors of record on Friday, November 22nd will be issued a $0.20 dividend. The ex-dividend date of this dividend is Friday, November 22nd. This represents a $0.80 dividend on an annualized basis and a yield of 2.55%. Bath & Body Works’s dividend payout ratio (DPR) is presently 19.37%.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on BBWI shares. Citigroup reduced their price target on Bath & Body Works from $48.00 to $35.00 and set a “neutral” rating on the stock in a research report on Tuesday, August 20th. Barclays cut Bath & Body Works from an “equal weight” rating to an “underweight” rating and decreased their price target for the stock from $31.00 to $28.00 in a research report on Friday, November 8th. Robert W. Baird dropped their price target on Bath & Body Works from $54.00 to $45.00 and set an “outperform” rating for the company in a research note on Thursday, August 29th. Raymond James reduced their price objective on shares of Bath & Body Works from $51.00 to $42.00 and set an “outperform” rating on the stock in a research note on Thursday, August 29th. Finally, Deutsche Bank Aktiengesellschaft dropped their target price on shares of Bath & Body Works from $57.00 to $54.00 and set a “buy” rating for the company in a research report on Monday, August 26th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and nine have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $42.44.

Insider Buying and Selling

In related news, CEO Gina Boswell purchased 6,000 shares of Bath & Body Works stock in a transaction on Wednesday, October 9th. The shares were purchased at an average price of $29.64 per share, for a total transaction of $177,840.00. Following the transaction, the chief executive officer now owns 242,987 shares of the company’s stock, valued at approximately $7,202,134.68. This represents a 2.53 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this hyperlink. 0.27% of the stock is owned by corporate insiders.

Bath & Body Works Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.